Healthcare

NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close

SHELTON, CONNECTICUT / ACCESS Newswire / November 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced that it...

VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge

SAN JOSE, CALIFORNIA / ACCESS Newswire / November 11, 2025 / VSee Health, Inc. (Nasdaq:VSEE) a leader in HIPAA-compliant telemedicine...

Altimmune Announces Publication of IMPACT Phase 2b Trial Data in The Lancet and Concurrent Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2025

24-week data demonstrated significant MASH resolution and weight loss, and strong evidence of anti-fibrotic activity with a favorable tolerability profile...

MGI Tech Joins Forces with SAMRC and DSTI to Launch South Africa’s 110K Human Genome Program and Unveil Africa’s First DNBSEQ-T7, Ushering a New Era in African Genomics

Cosmo’s ESG Rating Upgraded by S&P Global; Strengthens Supplier Sustainability Oversight Engagement, and Italian Manufacturing Plant Awarded EcoVadis Bronze Medal

Dublin, Ireland--(Newsfile Corp. - November 11, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and...

FACT’s New Standards for Immune Effector Cells in the Community Clinical Setting Help Bring Cell Therapies Closer to Patients

Consensus-Built ‘Fit-for-Purpose' Quality and Safety Standards for Community Oncology Programs OMAHA, NEBRASKA / ACCESS Newswire / November 10, 2025 /...

FACT’s New Standards for Immune Effector Cells in the Community Clinical Setting Help Bring Cell Therapies Closer to Patients

Consensus-Built ‘Fit-for-Purpose' Quality and Safety Standards for Community Oncology Programs OMAHA, NEBRASKA / ACCESS Newswire / November 10, 2025 /...

error: Content is protected !!